Amman Bradford K. 4
4 · Vivos Therapeutics, Inc. · Filed May 25, 2021
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-05-25$5.29/sh+1,000$5,290→ 2,000 total
Holdings
- 100,000
Stock Option
Exercise: $7.50Exp: 2026-03-12→ Common Stock (100,000 underlying) - 83,334
Stock Option
Exercise: $7.50Exp: 2023-10-22→ Common Stock (83,334 underlying) - 16,667
Stock Option
Exercise: $7.50Exp: 2024-11-18→ Common Stock (16,667 underlying)
Footnotes (3)
- [F1]100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.
- [F2]16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
- [F3]83,334 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.